Literature DB >> 24450944

Warfarin untargeted metabolomics study identifies novel procoagulant ethanolamide plasma lipids.

Hiroshi Deguchi1, Darlene J Elias, Sunia Trauger, Hui-Min Zhang, Ewa Kalisiak, Gary Siuzdak, John H Griffin.   

Abstract

Entities:  

Keywords:  lipids; mass spectrometry; thrombin; warfarin

Mesh:

Substances:

Year:  2014        PMID: 24450944      PMCID: PMC3984601          DOI: 10.1111/bjh.12720

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  American Heart Association/American College of Cardiology Foundation guide to warfarin therapy.

Authors:  Jack Hirsh; Valentin Fuster; Jack Ansell; Jonathan L Halperin
Journal:  J Am Coll Cardiol       Date:  2003-05-07       Impact factor: 24.094

2.  Stereoselective interactions of warfarin enantiomers with the pregnane X nuclear receptor in gene regulation of major drug-metabolizing cytochrome P450 enzymes.

Authors:  A Rulcova; I Prokopova; L Krausova; M Bitman; R Vrzal; Z Dvorak; J Blahos; P Pavek
Journal:  J Thromb Haemost       Date:  2010-12       Impact factor: 5.824

3.  Development and validation of a quantitative method for the determination of 12 endocannabinoids and related compounds in human plasma using liquid chromatography-tandem mass spectrometry.

Authors:  Michiel G J Balvers; Kitty C M Verhoeckx; Renger F Witkamp
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-04-08       Impact factor: 3.205

Review 4.  Guidelines on oral anticoagulation with warfarin - fourth edition.

Authors:  David Keeling; Trevor Baglin; Campbell Tait; Henry Watson; David Perry; Caroline Baglin; Steve Kitchen; Michael Makris
Journal:  Br J Haematol       Date:  2011-06-14       Impact factor: 6.998

5.  Metabolomics implicates altered sphingolipids in chronic pain of neuropathic origin.

Authors:  Gary J Patti; Oscar Yanes; Leah P Shriver; Jean-Phillipe Courade; Ralf Tautenhahn; Marianne Manchester; Gary Siuzdak
Journal:  Nat Chem Biol       Date:  2012-01-22       Impact factor: 15.040

Review 6.  Innovation: Metabolomics: the apogee of the omics trilogy.

Authors:  Gary J Patti; Oscar Yanes; Gary Siuzdak
Journal:  Nat Rev Mol Cell Biol       Date:  2012-03-22       Impact factor: 94.444

7.  Simultaneous quantitative analysis of N-acylethanolamides in clinical samples.

Authors:  Aliye Ozalp; Begona Barroso
Journal:  Anal Biochem       Date:  2009-08-08       Impact factor: 3.365

8.  Poor prognosis in warfarin-associated intracranial hemorrhage despite anticoagulation reversal.

Authors:  Dar Dowlatshahi; Kenneth S Butcher; Negar Asdaghi; Susan Nahirniak; Manya L Bernbaum; Antonio Giulivi; Jason K Wasserman; Man-Chiu Poon; Shelagh B Coutts
Journal:  Stroke       Date:  2012-05-03       Impact factor: 7.914

9.  Possible Anandamide and Palmitoylethanolamide involvement in human stroke.

Authors:  Marcello Naccarato; Daniela Pizzuti; Stefania Petrosino; Marco Simonetto; Laura Ferigo; Fabio Chiodo Grandi; Gilberto Pizzolato; Vincenzo Di Marzo
Journal:  Lipids Health Dis       Date:  2010-05-14       Impact factor: 3.876

Review 10.  N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities.

Authors:  Stefania Petrosino; Teresa Iuvone; Vincenzo Di Marzo
Journal:  Biochimie       Date:  2010-01-21       Impact factor: 4.079

  10 in total
  5 in total

1.  Acylcarnitines are anticoagulants that inhibit factor Xa and are reduced in venous thrombosis, based on metabolomics data.

Authors:  Hiroshi Deguchi; Yajnavalka Banerjee; Sunia Trauger; Gary Siuzdak; Ewa Kalisiak; José A Fernández; Linh Hoang; Minerva Tran; Subramanian Yegneswaran; Darlene J Elias; John H Griffin
Journal:  Blood       Date:  2015-07-14       Impact factor: 22.113

2.  Molecular interaction site on procoagulant myosin for factor Xa-dependent prothrombin activation.

Authors:  Hiroshi Deguchi; Zihan Guo; Mohammed Hayat; Elsa Pflimlin; Sam Lear; Weijun Shen; John H Griffin
Journal:  J Biol Chem       Date:  2019-09-03       Impact factor: 5.157

3.  Elevated CETP Lipid Transfer Activity is Associated with the Risk of Venous Thromboembolism.

Authors:  Hiroshi Deguchi; Yajnavalka Banerjee; Darlene J Elias; John H Griffin
Journal:  J Atheroscler Thromb       Date:  2016-05-09       Impact factor: 4.928

4.  Minor Plasma Lipids Modulate Clotting Factor Activities and May Affect Thrombosis Risk.

Authors:  Hiroshi Deguchi; Darlene J Elias; John H Griffin
Journal:  Res Pract Thromb Haemost       Date:  2017-06-20

5.  Application of plasma metabolome for monitoring the effect of rivaroxaban in patients with nonvalvular atrial fibrillation.

Authors:  Mindi Zhao; Xiaoyan Liu; Xiaoxiao Bu; Yao Li; Meng Wang; Bo Zhang; Wei Sun; Chuanbao Li
Journal:  PeerJ       Date:  2022-08-09       Impact factor: 3.061

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.